Recent study has recognized that rapidly accelerated fibrosarcoma (Raf)/mitogen‐activated protein kinase (MEK)/extracellular signal–regulated kinase (ERK) signalling pathway activation plays critical roles in cancer growth, survival and motility, as well as targeted therapy resistance mechanisms during various stages of cancer.37 The gene discussed is RAF1; the disease is fibrosarcoma.